FAT1 and neoplasm: In conclusion, our study revealed that FAT mutations enhanced tumor immunogenicity (e.g., TMB and DDR mutations) and contributed to an inflammatory TME, thereby significantly improving the prognosis of patients with STAD, which might be a positive prognostic marker for STAD.